Perry RR - Search Results

1

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer.

van Reesema LLS, Zheleva V, Winston JS, Jansen RJ, O'Connor CF, Isbell AJ, Bian M, Qin R, Bassett PT, Hinson VJ, Dorsch KA, Kirby BW, Van Sciver RE, Tang-Tan AM, Harden EA, Chang DZ, Allen CA, Perry RR, Hoefer RA, Tang AH. van Reesema LLS, et al. Among authors: perry rr. EBioMedicine. 2016 Sep;11:183-198. doi: 10.1016/j.ebiom.2016.08.014. Epub 2016 Aug 14. EBioMedicine. 2016. PMID: 27569656 Free PMC article.

2

RAS pathway biomarkers for breast cancer prognosis.

Siewertsz van Reesema LL, Lee MP, Zheleva V, Winston JS, O'Connor CF, Perry RR, Hoefer RA, Tang AH. Siewertsz van Reesema LL, et al. Among authors: perry rr. Clin Lab Int. 2016 Nov;40:18-23. Clin Lab Int. 2016. PMID: 28579913 Free PMC article.

3

Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection.

Fournier K, Schiller A, Perry RR, Laronga C. Fournier K, et al. Among authors: perry rr. Ann Surg. 2004 Jun;239(6):859-63; discussion 863-5. doi: 10.1097/01.sla.0000128302.05898.a7. Ann Surg. 2004. PMID: 15166965 Free PMC article.

4

Changes in male breast cancer over a 30-year period.

Schaub NP, Maloney N, Schneider H, Feliberti E, Perry R. Schaub NP, et al. Am Surg. 2008 Aug;74(8):707-11; discussion 711-2. Am Surg. 2008. PMID: 18705571

5

Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.

Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, Feliberti EC, Perry RR, Drake RR. Schaub NP, et al. Among authors: perry rr. J Am Coll Surg. 2009 May;208(5):970-8; discussion 978-80. doi: 10.1016/j.jamcollsurg.2008.12.024. Epub 2009 Mar 26. J Am Coll Surg. 2009. PMID: 19476873

6

Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer.

Hughes M, Goffman TG, Perry RR, Laronga C. Hughes M, et al. Among authors: perry rr. Am J Surg. 2004 Jan;187(1):52-7. doi: 10.1016/j.amjsurg.2003.04.004. Am J Surg. 2004. PMID: 14706586

7

Serum biomarkers to differentiate benign and malignant mammographic lesions.

Shin S, Cazares L, Schneider H, Mitchell S, Laronga C, Semmes OJ, Perry RR, Drake RR. Shin S, et al. Among authors: perry rr. J Am Coll Surg. 2007 May;204(5):1065-71; discussion 1071-3. doi: 10.1016/j.jamcollsurg.2007.01.036. J Am Coll Surg. 2007. PMID: 17481542

8

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL Jr, Drake RR, Semmes OJ. Laronga C, et al. Among authors: perry rr. Dis Markers. 2003-2004;19(4-5):229-38. doi: 10.1155/2004/759530. Dis Markers. 2003. PMID: 15258337 Free PMC article.

9

Hormone status and demographics in early onset breast cancer patients.

Friend KE, Perry RR, Collins JN, Britt RC, Feliberti EC. Friend KE, et al. Among authors: perry rr. Am Surg. 2012 Jul;78(7):819-21. Am Surg. 2012. PMID: 22748546 No abstract available.

10

Merkel cell carcinoma: high recurrence rate despite aggressive treatment.

Soult MC, Feliberti EC, Silverberg ML, Perry RR. Soult MC, et al. Among authors: perry rr. J Surg Res. 2012 Sep;177(1):75-80. doi: 10.1016/j.jss.2012.03.067. Epub 2012 Apr 16. J Surg Res. 2012. PMID: 22537840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page